Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
- 9 December 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 137 (2), 465-470
- https://doi.org/10.1007/s10549-012-2355-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- 1st International consensus guidelines for advanced breast cancer (ABC 1)The Breast, 2012
- Use of Tamoxifen With Postsurgical Irradiation May Improve Survival in Estrogen and Progesterone Receptor–Positive Male Breast CancerClinical Breast Cancer, 2011
- Multidisciplinary Meeting on Male Breast Cancer: Summary and Research RecommendationsJournal of Clinical Oncology, 2010
- Male breast cancer: is the scenario changingWorld Journal of Surgical Oncology, 2008
- Male breast cancer: a review of clinical managementBreast Cancer Research and Treatment, 2006
- Male breast cancerThe Lancet, 2006
- A Review of the Diagnosis and Management of Male Breast CancerThe Oncologist, 2005
- Breast carcinoma in menCancer, 2004
- Comparison of prognostic markers detected by immunohistochemistry in male and female breast carcinomasEuropean Journal of Cancer, 1996
- Male breast cancer: Results of the treatments and prognostic factors in 397 casesEuropean Journal of Cancer, 1995